Home
>
National Drug Code (NDC)
>
Oregon Ash
Oregon Ash - 49288-0020-4 - (Oregon Ash)
Drug Information of Oregon Ash
| Product NDC: | 49288-0020 |
| Proprietary Name: | Oregon Ash |
| Non Proprietary Name: | Oregon Ash |
| Active Ingredient(s): | .05 g/mL & nbsp; Oregon Ash |
| Administration Route(s): | INTRADERMAL; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Oregon Ash
| Product NDC: | 49288-0020 |
| Labeler Name: | Antigen Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA102223 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19740423 |
Package Information of Oregon Ash
| Package NDC: | 49288-0020-4 |
| Package Description: | 30 mL in 1 VIAL, MULTI-DOSE (49288-0020-4) |
NDC Information of Oregon Ash
| NDC Code | 49288-0020-4 |
| Proprietary Name | Oregon Ash |
| Package Description | 30 mL in 1 VIAL, MULTI-DOSE (49288-0020-4) |
| Product NDC | 49288-0020 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Oregon Ash |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRADERMAL; SUBCUTANEOUS |
| Start Marketing Date | 19740423 |
| Marketing Category Name | BLA |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | FRAXINUS LATIFOLIA POLLEN |
| Strength Number | .05 |
| Strength Unit | g/mL |
| Pharmaceutical Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
